Renal Unit, Ikegami General Hospital, Tokyo, Japan.
Nephron Clin Pract. 2013;124(1-2):23-30. doi: 10.1159/000353733. Epub 2013 Sep 12.
Vascular access (VA) guidelines recommend the native arteriovenous fistula (AVF) as VA of first choice for chronic hemodialysis patients. AVF management is important in hemodialysis patient care. AVF survival is associated with various physical factors, but the effects of dialysis treatment factors upon AVF survival are still not clear.
Study patients were treated at 498 dialysis facilities participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS) 2 or 3 (2002-2007). Analyses included 1,183 incident hemodialysis patients (on dialysis ≤7 days and using an AVF at study entry) and 949 prevalent patients (on dialysis >7 days at DOPPS entry and using a new AVF created during study observation). AVF survival was modeled from the study entry date for incident patients and date of first AVF use for prevalent patients. Predictors of primary and final AVF survival were compared across Japan, North America and Europe/Australia/New Zealand (EUR/ANZ) with adjustments for patient characteristics.
No meaningful relationship was seen between AVF survival and various physician and staff practices. However, patients with prior catheter use displayed higher rates of primary and final AVF failure. Final AVF failure rates were higher in facilities with higher median blood flow rates (BFR). They were also greater in North America and EUR/ANZ than in Japan, but this difference was substantially attenuated after accounting for regional differences in facility median BFR.
AVF longevity differed according to the DOPPS region, and was related to prior patient catheter use and facility BFR practice. Further longitudinal studies may help demonstrate meaningful associations between VA-handling skill and patency.
血管通路(VA)指南建议自体动静脉瘘(AVF)作为慢性血液透析患者的首选 VA。AVF 的管理在血液透析患者的护理中非常重要。AVF 的生存与各种身体因素有关,但透析治疗因素对 AVF 生存的影响尚不清楚。
研究对象接受了来自参与 DOPPS 2 或 3 期(2002-2007 年)的 498 个透析中心的治疗。分析包括 1183 例新发生的血液透析患者(开始透析 ≤7 天,研究入组时使用 AVF)和 949 例现患患者(开始透析 >7 天,DOPPS 入组时使用新创建的 AVF)。对新发生的患者从研究入组日期开始,对现患患者从首次使用 AVF 的日期开始对 AVF 生存进行建模。调整患者特征后,比较了日本、北美和欧洲/澳大利亚/新西兰(EUR/ANZ)之间原发性和最终 AVF 生存的预测因素。
没有发现 AVF 生存与各种医生和工作人员实践之间存在有意义的关系。然而,有导管使用史的患者原发性和最终 AVF 失败的发生率更高。血流量较高的设施(BFR)的最终 AVF 失败率更高。北美的 AVF 失败率和 EUR/ANZ 高于日本,但在考虑到设施 BFR 的区域差异后,这一差异大大减弱。
AVF 的寿命因 DOPPS 区域而异,与患者导管使用史和设施 BFR 实践有关。进一步的纵向研究可能有助于证明 VA 处理技能与通畅性之间存在有意义的关联。